Initiation of Iron Chelation Therapy in Pediatric Patients
Primary Recommendation
- The American Society of Hematology recommends initiating iron chelation therapy in pediatric patients when serum ferritin reaches ≥1,000 ng/mL or when the transfusion burden is ≥2 units per month sustained for more than one year, provided the child has a life expectancy of at least one year 1, 2, 3
Key Initiation Criteria
Ferritin-Based Threshold
- Iron chelation therapy should be started when serum ferritin reaches 1,000 ng/mL, particularly in children with chronic transfusion-dependent conditions, as this threshold is associated with significantly worsened survival when exceeded 1, 2, 3, 4
Transfusion Burden Criteria
- The American Society of Hematology recommends initiating therapy when the transfusion requirement is ≥2 units/month for >1 year, as cardiac abnormalities develop after >100 units of transfusions and liver iron accumulation occurs after >24 units of transfusions 1, 2, 3, 5
- Cardiac abnormalities develop after >100 units of transfusions, indicating the need for close monitoring of transfusion burden 2, 4
- Liver iron accumulation occurs after >24 units of transfusions, highlighting the importance of regular assessment of iron stores 2, 4, 6
Special Clinical Scenarios Requiring Early Initiation
Pre-Transplant Patients
- Candidates for allogeneic stem cell transplant should be chelated early, even with moderate iron overload, as ferritin >1,000 ng/mL at transplant is associated with higher mortality 7
- Iron chelation prior to transplant decreases procedure-related hepatic complications, emphasizing the importance of pre-transplant chelation 1, 3, 5
Organ Preservation
- Initiate chelation when there is a need to preserve organ function, regardless of ferritin level, as this applies even in patients with life expectancy <1 year if they already show signs of iron-related organ complications 1, 2, 3, 4, 8
- Cardiac T2* <20 milliseconds by MRI indicates significant heart iron overload and warrants chelation, highlighting the importance of regular monitoring of cardiac function 7
Monitoring Requirements Before and During Therapy
Baseline Assessment
- Assess body iron stores at diagnosis of the underlying condition, and establish a transfusion tracking system to monitor cumulative burden 2, 3, 6, 9, 10
Ongoing Monitoring
- Check serum ferritin every 3 months (monthly if possible) in transfusion-dependent patients, and monitor organ function periodically 1, 2, 3, 5, 6, 9, 10
Patient Selection Algorithm
- Initiate chelation if ANY of the following: serum ferritin ≥1,000 ng/mL with ongoing transfusions, transfusion burden ≥2 units/month for >1 year, candidate for allogeneic transplant with elevated iron stores, evidence of organ dysfunction from iron overload, or life expectancy ≥1 year 1, 2, 3, 5, 7
- Do NOT initiate if life expectancy <1 year without existing organ damage, emphasizing the importance of careful patient selection 1, 5